Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00767455 · ClinicalTrials.gov registry record · Phase 1
Cumulative Irritation Potential of 828 Ointment
A Phase 1 study of Healthy Volunteers, sponsored by Healthpoint.
- Completed
- Registry status
- Phase 1
- Development phase
- 59
- Enrollment target
- 1
- Study location
NCT00767455: Completed Phase 1 study of Healthy Volunteers, sponsored by Healthpoint.
NCT00767455 is a Phase 1 study of Healthy Volunteers that has completed, run by Healthpoint. The registered enrollment target is 59 participants, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00767455, a Phase 1 study of Healthy Volunteers, has completed, sponsored by Healthpoint.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 59 participants
- Enrollment target
- 1
- Study location
Study Summary
Cumulative Irritation Patch Test
Primary Outcome
Irritancy of each test article was evaluated by assessment of the application sites using the Berger and Bowman Scale. Observed responses (e.g., erythema and edema) were graded according to the protocol-specified grading scale \[0 (no visible reaction) to 4 (severe erythema)\] for each subject. The relative cumulative irritation potentials of the test article (HP828-101 Ointment) and the negative and positive controls were determined by summing the daily scores of the 21 days of testing; with an
Conditions Studied
Interventions
- DEVICE HP828-101
Study Locations (1)
Texas
- RCTS, Inc. - Irving
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2008-10 |
| Est. Completion | 2008-11 |
| Phase | Phase 1 |
What the finished NCT00767455 record still lists
NCT00767455 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Healthy Volunteers appearing as the primary indexed condition, and to 1 intervention - of which HP828-101 is the first listed.
NCT00767455 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00767455 about?
NCT00767455 is a clinical study titled "Cumulative Irritation Potential of 828 Ointment". Cumulative Irritation Patch Test
What is the current status of trial NCT00767455?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 59 participants. The study started on 2008-10. Estimated completion is 2008-11.
What conditions does trial NCT00767455 study?
This clinical trial studies the following conditions: Healthy Volunteers.
What interventions are being tested in trial NCT00767455?
The interventions under investigation include: HP828-101 (DEVICE).
Who is sponsoring clinical trial NCT00767455?
This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00767455 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00767455's enrollment target sits among peer trials
59 122nd of 283 higher than 161 of 283 other Healthy Volunteers trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Volunteers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
RECRUITING · Phase 1
-
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.
RECRUITING · Phase 1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult Participants
RECRUITING · Phase 1
-
A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.
RECRUITING · Phase 1
-
Classroom Break, Cognition, and Fitness in Elementary School Children
RECRUITING · Phase 1
-
A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia